Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive versus post-operative lumiracoxib for pain after ambulatory arthroscopic knee surgery
2005-005949-19Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lumiracoxib in postoperative pain (3 arms), sponsored by Novartis. Primary endpoint: Pain intensity in the target knee after movement at 2 hours. Started May 2006; status: completed.
02
Drugs
lumiracoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2005-005949-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005949-19.